{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:06:49Z","timestamp":1790165209393,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC2304604"],"award-info":[{"award-number":["2022YFC2304604"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC2304605"],"award-info":[{"award-number":["2022YFC2304605"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.rpth.2026.106843","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:06:54Z","timestamp":1784045214000},"page":"106843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of von Willebrand factor and ADAMTS-13 in patients with sepsis-induced coagulopathy"],"prefix":"10.1016","volume":"10","author":[{"given":"Feng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0833-2248","authenticated-orcid":false,"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106843_bib1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2026.106843_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.rpth.2026.106843_bib3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106843_bib4","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106843_bib5","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/trf.14804","article-title":"ADAMTS13: origins, applications, and prospects","volume":"58","author":"Plautz","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.rpth.2026.106843_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10237-023-01803-5","article-title":"Numerical study of ultra-large von Willebrand factor multimers in coagulopathy","volume":"23","author":"Rahmati","year":"2024","journal-title":"Biomech Model Mechanobiol"},{"key":"10.1016\/j.rpth.2026.106843_bib7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/10408363.2018.1529734","article-title":"D-dimer: preanalytical, analytical, postanalytical variables, and clinical applications","volume":"55","author":"Favresse","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.rpth.2026.106843_bib8","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood.2023021265","article-title":"Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis","volume":"143","author":"El Otmani","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106843_bib9","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.3390\/ijms25158137","article-title":"ADAMTS13 in the new era of TTP","volume":"25","author":"Papakonstantinou","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rpth.2026.106843_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10456-021-09789-3","article-title":"Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF\/ADAMTS13 ratio imbalance","volume":"24","author":"Philippe","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.rpth.2026.106843_bib11","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.3390\/jcm12227174","article-title":"Dynamic assessment of plasma von Willebrand factor and ADAMTS13 predicts mortality in hospitalized patients with SARS-CoV-2 infection","volume":"12","author":"Zhang","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.rpth.2026.106843_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.thromres.2022.08.017","article-title":"Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: a systematic review and meta-analysis","volume":"218","author":"Xu","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106843_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/ijlh.13785","article-title":"Prognostic value of the ADAMTS13-vWF axis in disseminated intravascular coagulation: platelet count\/vWF:Ag ratio as a strong prognostic marker","volume":"44","author":"Jang","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2026.106843_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247017","article-title":"Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients","volume":"16","author":"Singh","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2026.106843_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/jth.13953","article-title":"The role of ADAMTS-13 in the coagulopathy of sepsis","volume":"16","author":"Levi","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106843_bib16","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2147\/JIR.S504184","article-title":"The mechanisms of sepsis induced coagulation dysfunction and its treatment","volume":"18","author":"Zhu","year":"2025","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.rpth.2026.106843_bib17","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jtha.2025.03.038","article-title":"Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation","volume":"23","author":"Iba","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106843_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SHK.0000000000001823","article-title":"Distinctive biomarker features in the endotheliopathy of COVID-19 and septic syndromes","volume":"57","author":"Fern\u00e1ndez","year":"2022","journal-title":"Shock"},{"key":"10.1016\/j.rpth.2026.106843_bib19","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1093\/eurheartj\/ehae517","article-title":"Von Willebrand factor exacerbates heart failure through formation of neutrophil extracellular traps","volume":"45","author":"Mang","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2026.106843_bib20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1055\/s-0041-1733800","article-title":"Inverse regulation of confluence-dependent ADAMTS13 and von Willebrand factor expression in human endothelial cells","volume":"122","author":"Popa","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106843_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.610696","article-title":"Insights into immunothrombosis: the interplay among neutrophil extracellular trap, von Willebrand factor, and ADAMTS13","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2026.106843_bib22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2004-06-2096","article-title":"Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin","volume":"105","author":"Studt","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106843_bib23","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/jth.15873","article-title":"Mechanisms of ADAMTS13 regulation","volume":"20","author":"DeYoung","year":"2022","journal-title":"J Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926035016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926035016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:50:49Z","timestamp":1790164249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926035016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2475037926035016"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106843","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of von Willebrand factor and ADAMTS-13 in patients with sepsis-induced coagulopathy","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106843"}}